Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Endocrine/Neuroendocrine Cancers

Safety and Efficacy of Lu-177-DOTATATE in Metastatic or Inoperable Pheochromocytoma/Paraganglioma – An Interim Analysis

Frank Lin, Jorge Carrasquillo, Jaydira del Rivero, Inna Shamis, Joy Zou, Baris Turkbey, Abhishek Jha, Joanna Klubo-Gwiezdzinska, Yating Teng, Esther Mena, Liza Lindenberg, Clara Chen, Corina Millo, Peter Herscovitch and Karel Pacak
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P1296;
Frank Lin
1National Cancer Institute. NIH.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorge Carrasquillo
2MIB, NCI, NIH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaydira del Rivero
3National Cancer Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inna Shamis
3National Cancer Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joy Zou
3National Cancer Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Baris Turkbey
1National Cancer Institute. NIH.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abhishek Jha
4Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanna Klubo-Gwiezdzinska
5National Institutes of Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yating Teng
6Henry M. Jackson Foundation for the Advancement of Military Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esther Mena
7National Cancer Institute. NIH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liza Lindenberg
8MIB, NCI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clara Chen
5National Institutes of Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Corina Millo
5National Institutes of Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Herscovitch
5National Institutes of Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karel Pacak
4Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Safety and Efficacy of Lu-177-DOTATATE in Metastatic or Inoperable Pheochromocytoma/Paraganglioma – An Interim Analysis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Safety and Efficacy of Lu-177-DOTATATE in Metastatic or Inoperable Pheochromocytoma/Paraganglioma – An Interim Analysis
Frank Lin, Jorge Carrasquillo, Jaydira del Rivero, Inna Shamis, Joy Zou, Baris Turkbey, Abhishek Jha, Joanna Klubo-Gwiezdzinska, Yating Teng, Esther Mena, Liza Lindenberg, Clara Chen, Corina Millo, Peter Herscovitch, Karel Pacak
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P1296;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Safety and Efficacy of Lu-177-DOTATATE in Metastatic or Inoperable Pheochromocytoma/Paraganglioma – An Interim Analysis
Frank Lin, Jorge Carrasquillo, Jaydira del Rivero, Inna Shamis, Joy Zou, Baris Turkbey, Abhishek Jha, Joanna Klubo-Gwiezdzinska, Yating Teng, Esther Mena, Liza Lindenberg, Clara Chen, Corina Millo, Peter Herscovitch, Karel Pacak
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P1296;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Comparison of 18F-MFBG PET/CT and MRI in the evaluation of Neuroblastoma
  • Characterizing Early Disease Progression in GEP-NET Patients After Peptide Receptor Radionuclide Therapy (PRRT)
  • Diagnostic value of PET/MR in Functional nodules of Primary Aldosteronism
Show more Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Endocrine/Neuroendocrine Cancers

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire